Thomas Broeer elected as new BGMA chair
This article was originally published in Scrip
Executive Summary
The British Generic Manufacturers Association (BGMA) has appointed Thomas Broeer, managing director of Kent Pharmaceuticals, as its new chair for the next two years. He replaces Kim Innes, a director at Teva, who will continue for a further year as vice-chair of the association, which is the generic industry's trade body representing more than 90% of the UK supply market. Before taking up the role with Kent, Mr Broeer held senior management roles at Mylan in the UK and Germany.